1Hunt SA,Baker DW,Chin MH,et al.ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult:executive summary[J].JACC,2001,38:2101-2113.
2Hunt SA,Abraham WT,Chin MH,et al.ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)[J].Circulation,2005,112:154-235.
3Muller C,Scholer A,Laule-Kilian K,et al.Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea[J].N Engl J Med,2004,350:647-654.
4Allman KC,Shaw LJ,Hachamovitch R,et al.Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction:a meta-analysis[J].J Am Coll Cardiol,2002,39:1151-1158.
5Mason JW,Connell JB,Herskowitz A,et al.A clinical trial of immunosuppressive therapy for myocarditis[J].N Engl J Med,1995,333:269-275.
6Fox KM.Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease:randomised,double-blind,placebo-controlled,multicentre trial(the EUROPA study)[J].Lancet,2003,362:782-788.
7Heart Outcomes Prevention Evaluation Study Investigators.Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus:results of the HOPE study and MICROHOPE substudy[J].Lancet,2000,355:253-259.
